(CMR) Dr. Sook Yin of the Perseus Cayman Limited company is seeking 20 volunteers to participate in phase one of the human clinical trials for a COVID-19 vaccine.
As the race to developed a vaccine gets underway a US-based company with Cayman connections is hoping to conduct clinical trials here.
It has been revealed that the Cayman Islands Health Practice Commission has approved the application despite their website has no information on the decision. Perseus Cayman has now partnered with US-based partners.
Dr. Yin is the medical director of Perseus Cayman. Their website shared that they specialize in cancer treatment vaccines and that they have been successfully and safely conducting clinical trials in the field of cancer immunotherapy since 2012.
They hope to build on that success story along with their US partners, Orbis Health Solutions, LLC. (Orbis). Perseus PCI (Personalized Cancer Immunization) set up in Cayman in March 2013 and started accepting patients. Perseus is a wholly-owned subsidiary and serves as a treatment arm of Orbis.
Dr. Thomas E. Wagner (72) is a co-founder of Perseus PCI and CEO of Orbis for the past 11 years and a Greenville biomedical researcher. His wife is Wuhan China, the epicenter and origins of COVID-19.
The Perseus website shared that Wagner:
is a world-renowned biomedical scientist, innovator and entrepreneur”. His specialty is gene-based medicine and other aspects of the biotech industry. The website shares that he has attracted more than $25 million in research funding and has held prestigious faculty and research positions at institutions such as Cornell University of Medicine, The Sloan Kettering Institute for Cancer Research and Cambridge University.
In the early 1980s, he co-founded Diagnostic Hybrids, which makes and markets cellular and molecular diagnostic kits used for respiratory and other diseases. He is a founder of the Ohio Edison Biotechnology Institute and formerly directed the Greenville Health System’s Oncology Research Institute and Clemson University’s Biomedical Institute. He currently is a director of the Orbis Health Solutions medical research firm in Greenville, a funding partner of Perseus.
Orbis was founded in 2009 by Dr. Wagner after 12 years of research in the development of therapeutic vaccines for the treatment of 15 different solid tumors types.
Perseus PCI was established in the Cayman Islands as a wholly-owned subsidiary of Perseus Holdings USA, LLC and as the treatment center for the Company, responsible for conducting the Phase I TLPLDC basket clinical trial in a variety of solid tumor types.
Anyone interested in volunteering to take part is asked to contact Dr. Sook Yin, the company’s principal investigator, by email at [email protected].
Insurance does not cover treatment at the Perseus clinic, which can cost between $40,000 and $100,000. It was reported in 2013 that the wait to get FDA approval was too long and Cayman presented opportunities to move forward years earlier. The cancer vaccine involves injecting patients with a vaccine made from their own tumor cells. He said the cells are injected just under the skin like other vaccines.